Mercado europeo de servicios de diagnóstico de trasplantes mediante tipificación de HLA: tendencias de la industria y pronóstico hasta 2028

Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado europeo de servicios de diagnóstico de trasplantes mediante tipificación de HLA: tendencias de la industria y pronóstico hasta 2028

  • Healthcare
  • Upcoming Report
  • Jun 2021
  • Europe
  • 350 Páginas
  • Número de tablas: 220
  • Número de figuras: 60

Europe Hla Typing Transplant Diagnostics Services Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) :  % Diagram

Diagram Período de pronóstico
2022 –2028
Diagram Tamaño del mercado (año base)
MILLONES DE DÓLARES
Diagram Tamaño del mercado (año de pronóstico)
MILLONES DE DÓLARES
Diagram Tasa de crecimiento anual compuesta (CAGR)
%
Diagram Jugadoras de los principales mercados
  • One Lambda
  • HistoGenetics LLC
  • UCLA Health
  • Creative Biolabs
  • ProImmune

>Mercado europeo de servicios de diagnóstico de trasplantes mediante tipificación de HLA, por tecnología (tecnologías de ensayo molecular, tecnologías de ensayo no molecular), producto y servicio (reactivos y consumibles, instrumentos, software y servicios), aplicación (aplicaciones de diagnóstico, aplicaciones de investigación), usuario final (laboratorios de referencia independientes, hospitales y centros de trasplantes, laboratorios de investigación e institutos académicos), país (Alemania, Reino Unido, Francia, España, Italia, Rusia, Turquía, Bélgica, Países Bajos, Suiza, resto de Europa), tendencias de la industria y pronóstico hasta 2028.

Mercado de servicios de diagnóstico de trasplantes con tipificación HLAAnálisis y perspectivas del mercado: mercado europeo de servicios de diagnóstico de trasplantes con tipificación de HLA

Se espera que el mercado de servicios de diagnóstico de trasplantes con tipificación de HLA experimente un crecimiento del mercado a una tasa del 9,50% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 583,95 millones para 2028. El informe de investigación de mercado de Data Bridge sobre el mercado de servicios de diagnóstico de trasplantes con tipificación de HLA proporciona análisis e información sobre los diversos factores que se espera que prevalezcan durante el período de pronóstico, al tiempo que proporciona sus impactos en el crecimiento del mercado. El aumento de la prevalencia de enfermedades infecciosas está acelerando el crecimiento del mercado de servicios de diagnóstico de trasplantes con tipificación de HLA.

La tipificación de HLA ayuda a reconocer el grupo excepcional de antígenos HLA de un individuo. Los procedimientos de diagnóstico molecular basados ​​en el ADN ayudan a identificar los antígenos HLA de clase I y clase II. La tipificación de HLA utiliza innovaciones avanzadas en el ADN para ofrecer resultados de pruebas más precisos y rigurosos que se consideran mucho más confiables para identificar diferencias en los genes HLA.

El aumento de la inversión en actividades de investigación y desarrollo en toda la región actúa como uno de los principales factores que impulsan el crecimiento del mercado de servicios de diagnóstico de trasplantes de tipificación de HLA. El aumento en el número de procedimientos como el trasplante de órganos sólidos, células madre y tejidos blandos y el aumento de la financiación pública-privada para actividades de investigación específicas aceleran el crecimiento del mercado. El aumento de la popularidad de los diagnósticos moleculares entre los consumidores debido a su capacidad para ofrecer resultados precisos en menos tiempo y la gran cantidad y tamaño de laboratorios presentes en la región influyen aún más en el mercado. Además, la infraestructura sanitaria bien desarrollada, la alta conciencia entre las personas, el alto gasto sanitario y la rápida adopción de técnicas avanzadas afectan positivamente al mercado de servicios de diagnóstico de trasplantes de tipificación de HLA. Además, los avances tecnológicos en los instrumentos amplían las oportunidades rentables para los actores del mercado en el período de pronóstico de 2021 a 2028.

On the other hand, high cost associated with the polymerase chain reaction-based technological devices is expected to obstruct the market growth. The unfavorable reimbursement policies for organ transplantation and donation procedures are projected to challenge the HLA typing transplant diagnostics services market in the forecast period of 2021-2028.

This HLA typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on HLA typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

HLA Typing Transplant Diagnostics Services Market Scope and Market Size

The HLA typing transplant diagnostics services market is segmented on the basis of technology, product and services, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of technology, HLA typing transplant diagnostics services market is segmented into molecular assay technologies and non-molecular assay technologies. Molecular assay technologies are further segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further sub-segmented into real-time PCR, sequence-specific primer-PCR, sequence-specific oligonucleotide-PCR and other PCR-based molecular assays. Sequencing-based molecular assays are further sub-segmented into sanger sequencing, next-generation sequencing and other sequencing-based molecular assays.
  • On the basis of product and service, HLA typing transplant diagnostics services market is segmented into reagents and consumables, instruments and software and services.
  • On the basis of application, HLA typing transplant diagnostics services market is segmented into diagnostic applications and research applications. Diagnostic applications are further segmented into antibody screening, chimerism monitoring and others.
  • On the basis of end user, HLA typing transplant diagnostics services market is segmented into independent reference laboratories, hospitals and transplant centers and research laboratories and academic institutes.

Europe HLA Typing Transplant Diagnostics Services Market Country Level Analysis

The HLA typing transplant diagnostics services market is analyzed and market size insights and trends are provided by country, technology, product and services, application and end user as referenced above.      

The countries covered in the Europe HLA typing transplant diagnostics services market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey and Rest of Europe.

Europe is considered the second largest region to dominate the HLA typing transplant diagnostics services market because of the rise in prevalence of chronic diseases such as cancer, cardiac, and renal associated diseases and continuous commercialization of innovative transplant diagnostic products within the region.

The country section of the HLA typing transplant diagnostics services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The HLA typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for HLA typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the HLA typing transplant diagnostics services market. The data is available for historic period 2010-2019. 

Competitive Landscape and HLA Typing Transplant Diagnostics Services Market Share Analysis

The HLA typing transplant diagnostics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to HLA typing transplant diagnostics services market.

Los principales actores incluidos en el informe de mercado de servicios de diagnóstico de trasplantes de tipificación de HLA son One Lambda, HistoGenetics LLC, UCLA Health, Creative Biolabs., ProImmune Ltd., Admera Health, Quick Biology Inc., New York Blood Center, The Sequencing Center, Versiti. y Laboratory Corporation of America Holdings., entre otros. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.


SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

TABLE OF CONTENTS EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. TECHNOLOGICAL ADVANCEMENTS IN HLA TYPING 3.1.2. INCREASING NUMBER OF SOLID ORGAN AND STEM CELL TRANSPLANTATION PROCEDURES 3.1.3. INCREASED RESEARCH GRANTS, FUNDS, AND PUBLIC-PRIVATE INVESTMENTS

3.2. RESTRAINTS

3.2.1. WEAK REIMBURSEMENTS FOR ORGAN DONATION AND TRANSPLANTATION PROCEDURES 3.2.2. EXPENSIVE NGS AND PCR-BASED DEVICES

3.3. OPPORTUNITIES

3.3.1. RISING HEALTHCARE INFRASTRUCTURE IN EMERGING NATIONS

3.4. CHALLENGES

3.4.1. SIGNIFICANT GAP BETWEEN NUMBER OF ORGANS DONATED AND ORGANS REQUIRED ANNUALLY 3.4.2. LACK OF TRAINED STAFF

4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY

6.1. OVERVIEW

6.2. NEXT-GENERATION SEQUENCING (NGS)

6.3. POLYMERASE CHAIN REACTION (PCR)

6.3.1. PCR SSOP (SEQUENCE-SPECIFIC OLIGONUCLEOTIDE) 6.3.2. PCR SSP (SEQUENCE-SPECIFIC PRIMER) 6.3.3. PCR-SBT (SEQUENCING BASED TYPING)

7. EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY END-USER

7.1. OVERVIEW 7.2. SPECIALTY CLINICS 7.3. HOSPITALS 7.4. TRANSPLANT CENTERS 7.5. ACADEMIC INSTITUTES

8. EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY GEOGRAPHY

8.1. EUROPE

8.1.1. GERMANY 8.1.2. FRANCE 8.1.3. U.K. 8.1.4. ITALY 8.1.5. SPAIN 8.1.6. SWITZERLAND 8.1.7. NETHERLANDS 8.1.8. BELGIUM 8.1.9. RUSSIA 8.1.10. TURKEY 8.1.11. REST OF EUROPE

9. EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICESMARKET, COMPANY LANDSCAPE

9.1. COMPANY SHARE ANALYSIS: EUROPE

10. COMPANY PROFILES

10.1. PROIMMUNE LTD.

10.1.1. COMPANY OVERVIEW 10.1.2. PROIMMUNE LTD.: COMPANY SNAPSHOT 10.1.3. PRODUCT PORTFOLIO 10.1.4. RECENT DEVELOPMENTS

10.2. CREATIVE BIOLABS

10.2.1. COMPANY OVERVIEW 10.2.2. CREATIVE BIOLABS: COMPANY SNAPSHOT 10.2.3. PRODUCT PORTFOLIO 10.2.4. RECENT DEVELOPMENTS

10.3. HISTOGENETICS LLC

10.3.1. COMPANY OVERVIEW 10.3.2. HISTOGENETICS LLC: COMPANY SNAPSHOT 10.3.3. PRODUCT PORTFOLIO 10.3.4. RECENT DEVELOPMENTS

10.4. THE UCLA IMMUNOGENETICS CENTER

10.4.1. COMPANY OVERVIEW 10.4.2. THE UCLA IMMUNOGENETICS CENTER:COMPANY SNAPSHOT 10.4.3. PRODUCT PORTFOLIO 10.4.4. RECENT DEVELOPMENTS

10.5. ADMERA HEALTH

10.5.1. COMPANY OVERVIEW 10.5.2. ADMERA HEALTH: COMPANY SNAPSHOT 10.5.3. PRODUCT PORTFOLIO 10.5.4. RECENT DEVELOPMENTS

10.6. QUICK BIOLOGY

10.6.1. COMPANY OVERVIEW 10.6.2. QUICK BIOLOGY: COMPANY SNAPSHOT 10.6.3. PRODUCT PORTFOLIO 10.6.4. RECENT DEVELOPMENTS

10.7. NEW YORK BLOOD CENTER

10.7.1. COMPANY OVERVIEW 10.7.2. NEW YORK BLOOD CENTER: COMPANY SNAPSHOT 10.7.3. PRODUCT PORTFOLIO 10.7.4. RECENT DEVELOPMENTS

10.8. THE SEQUENCING CENTER

10.8.1. COMPANY OVERVIEW 10.8.2. THE SEQUENCING CENTER: COMPANY SNAPSHOT 10.8.3. PRODUCT PORTFOLIO 10.8.4. RECENT DEVELOPMENTS

10.9. BLOODCENTER OF WISCONSIN

10.9.1. COMPANY OVERVIEW 10.9.2. BLOODCENTER OF WISCONSIN: COMPANY SNAPSHOT 10.9.3. PRODUCT PORTFOLIO 10.9.4. RECENT DEVELOPMENTS

10.10. LABORATORY CORPORATION OF AMERICA HOLDINGS

10.10.1. COMPANY OVERVIEW 10.10.2. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE ANALYSIS 10.10.3. PRODUCT PORTFOLIO 10.10.4. RECENT DEVELOPMENTS

10.11. THERMO FISHER SCIENTIFIC INC.

10.11.1. COMPANY OVERVIEW 10.11.2. THERMO FISHER SCIENTIFIC INC. :REVENUE ANALYSIS 10.11.3. PRODUCT PORTFOLIO 10.11.4. RECENT DEVELOPMENTS

11. RELATED REPORTS

Lista de Tablas

TABLE LIST EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET

TABLE 1 COST OF DIFFERENT NGS DEVICES TABLE 2 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2016– 2025 (USD MILLION) TABLE 3 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, NEXT-GENERATION SEQUENCING (NGS), BY REGION, 2016 – 2025 (USD MILLION) TABLE 4 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, POLYMERASE CHAIN REACTION (PCR), BY TECHNIQUE, 2016-2025 (USD MILLION) TABLE 5 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, POLYMERASE CHAIN REACTION (PCR), BY REGION, 2016 – 2025 (USD MILLION) TABLE 6 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY END-USER, 2016-2025 (USD MILLION) TABLE 7 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, SPECIALTY CLINICS, BY REGION, 2016 – 2025 (USD MILLION) TABLE 8 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, HOSPITALS, BY REGION, 2016 – 2025 (USD MILLION) TABLE 9 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, TRANSPLANT CENTERS, BY REGION, 2016 – 2025 (USD MILLION) TABLE 10 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, ACADEMIC INSTITUTES, BY REGION, 2016 – 2025 (USD MILLION) TABLE 11 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 12 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 13 EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 14 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 15 GERMANY HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 16 GERMANY POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 17 GERMANY HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 18 FRANCE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 19 FRANCE POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 20 FRANCE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 21 U.K. HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 22 U.K. POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 23 U.K. HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 24 ITALY HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 25 ITALY POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 26 ITALY HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 27 SPAIN HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 28 SPAIN POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 29 SPAIN HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 30 SWITZERLAND HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 31 SWITZERLAND POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 32 SWITZERLAND HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 33 NETHERLANDS HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 34 NETHERLANDS POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 35 NETHERLANDS HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY END-USER, 2016 - 2025 (USD MILLION) TABLE 36 BELGIUM HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 37 BELGIUM POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 38 BELGIUM HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 39 RUSSIA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 40 RUSSIA POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 41 RUSSIA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 42 TURKEY HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION) TABLE 43 TURKEY POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION) TABLE 44 TURKEY HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION) TABLE 45 REST OF EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET BY TECHNOLOGY, 2016 - 2025 (USD MILLION)

Lista de figuras

FIGURES LIST EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET

FIGURE 1 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: SEGMENTATION FIGURE 2 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: DATA TRIANGULATION FIGURE 3 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: RESEARCH SNAPSHOT FIGURE 4 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: BOTTOM UP APPROACH FIGURE 5 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: TOP DOWN APPROACH FIGURE 6 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: INTERVIEW DEMOGRAPHICS FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET FIGURE 8 HEALTHCARE EXPENDITURE IN FEW EMERGING COUNTRIES (2000, 2010 & 2014) FIGURE 9 NUMBER OF DONORS, RECIPEINTS AND WAITING PATIENTS IN U.S. FROM 2010 TO 2015 FIGURE 10 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: SEGMENTATION FIGURE 11 TECHNOLOGICAL ADVANCEMENTS IN HLA TYPING, INCREASING NUMBER OF SOLID ORGAN AND STEM CELL TRANSPLANTATION PROCEDURES ARE EXPECTED TO DRIVE THE MARKET FOR EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES IN THE FORECAST PERIOD 2018 TO 2025 FIGURE 12 POLYMERASE CHAIN REACTION (PCR) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET IN 2018 & 2025 FIGURE 13 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFI FIGURE 14 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2017 FIGURE 15 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: BY END-USER, 2017 FIGURE 16 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2017) FIGURE 17 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2017) FIGURE 18 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET : BY COUNTRY (2018 & 2025) FIGURE 19 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY COUNTRY (2017 & 2025) FIGURE 20 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY PRODUCT (2018 & 2025) FIGURE 21 EUROPE HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2017 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.